HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 276, Issue 21, 17770-17778, May 25, 2001

This Article Full Text Full Text (PDF) All Versions of this Article: 276/21/17770    most recent M010307200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ren, Y. Articles by Liao, W. S.-L. Search for Related Content PubMed PubMed Citation Articles by Ren, Y. Articles by Liao, W. S.-L. Social Bookmarking                      What's this?

Transcription Factor AP-2 Functions as a Repressor That Contributes to the Liver-specific Expression of Serum Amyloid A1 Gene^*

Yongsheng Ren and Warren S.-L. Liao

From the Department of Biochemistry and Molecular Biology, Program in Genes and Development, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030

We previously identified transcription factor AP-2 as the nuclear factor that interacts with the tissue-specific repressor element in the rat serum amyloid A1 (SAA1) promoter. In this report, we provide evidence for a second AP-2-binding site and show that both AP-2 sites participate in mediating the transcription repression of SAA1 promoter. This proximal AP-2 site overlaps with the NFB-binding site known to be essential for SAA1 promoter activity. Protein binding competition experiments demonstrated that AP-2 and NFB binding to these overlapping sites were mutually exclusive. Furthermore, the addition of AP-2 easily displaced prebound NFB, whereas NFB could not displace AP-2. These results thus suggest that one mechanism by which AP-2 negatively regulates SAA1 promoter activity may be by antagonizing the function of NFB. Consistent with a repression function, transient expression of AP-2 in HepG2 cells inhibited conditioned medium-induced SAA1 promoter activation. This inhibition was dependent on functional AP-2-binding sites, since mutation of AP-2-binding sites abolished inhibitory effects of AP-2 in HepG2 cells as well as resulted in derepression of the SAA1 promoter in HeLa cells. In addition to SAA1, we found that several other liver gene promoters also contain putative AP-2-binding sites. Some of these sequences could specifically inhibit AP-2·DNA complex formation, and for the human complement C3 promoter, overexpression of AP-2 also could repress its cytokine-mediated activation. Finally, stable expression of AP-2 in hepatoma cells significantly reduced the expression of endogenous SAA, albumin, and -fetoprotein genes. Taken together, our results suggest that AP-2 may function as a transcription repressor to inhibit the expression of not only SAA1 gene but also other liver genes in nonhepatic cells.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				J. S. Hale, T. J. Dahlem, R. L. Margraf, I. Debnath, J. J. Weis, and J. H. Weis Transcriptional control of Pactolus: evidence of a negative control region and comparison with its evolutionary paralogue, CD18 ({beta}2 integrin) J. Leukoc. Biol., August 1, 2006; 80(2): 383 - 398. [Abstract] [Full Text] [PDF]

				N. Zhang, M. H. Ahsan, A. F. Purchio, and D. B. West Serum Amyloid A-Luciferase Transgenic Mice: Response to Sepsis, Acute Arthritis, and Contact Hypersensitivity and the Effects of Proteasome Inhibition J. Immunol., June 15, 2005; 174(12): 8125 - 8134. [Abstract] [Full Text] [PDF]

				G.-P. Zhou, C. Wong, R. Su, S. C. Crable, K. P. Anderson, and P. G. Gallagher Human potassium chloride cotransporter 1 (SLC12A4) promoter is regulated by AP-2 and contains a functional downstream promoter element Blood, June 1, 2004; 103(11): 4302 - 4309. [Abstract] [Full Text] [PDF]

				S. Yu, S. L. Asa, R. J. Weigel, and S. Ezzat Pituitary Tumor AP-2{alpha} Recognizes a Cryptic Promoter in Intron 4 of Fibroblast Growth Factor Receptor 4 J. Biol. Chem., May 23, 2003; 278(22): 19597 - 19602. [Abstract] [Full Text] [PDF]

				D. Ulgiati, C. Pham, and V. M. Holers Functional Analysis of the Human Complement Receptor 2 (CR2/CD21) Promoter: Characterization of Basal Transcriptional Mechanisms J. Immunol., June 15, 2002; 168(12): 6279 - 6285. [Abstract] [Full Text] [PDF]